SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Shuttle Pharmaceuticals Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026
$4.72−0.36 (-7.09%)
Close on Oct 19, 2026
- Market cap
- $4.79M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$31.58 (−87.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $4.79M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.25
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$10.26M
- EPS, diluted
- -$71.60
- Book value per share
- $18.90
- Diluted shares
- 1M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Operating income
-$11.22M
Net income
-$10.26M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months